Skip to main content
. Author manuscript; available in PMC: 2017 Nov 30.
Published in final edited form as: Pediatr Res. 2017 May 31;82(3):465–473. doi: 10.1038/pr.2017.116

Figure 1.

Figure 1

Identification of cases and controls for development and validation cohorts. a) Patient encounters including intensive care (ICU patients) and without intensive care (non-ICU patients) identified for inclusion in the development cohort. b) Patient encounters including intensive care (ICU patients) and without intensive care (non-ICU patients) identified for inclusion in the validation cohort. AKI – acute kidney injury; CKD – chronic kidney disease; ICU – intensive care unit; SCr – serum creatinine.